Login to Your Account



Strong Data Have Nitec Eying 2010 Filing in RA for Lodotra

By Cormac Sheridan


Wednesday, September 2, 2009
Nitec Pharma AG has obtained positive data from a second Phase III trial of Lodotra in rheumatoid arthritis (RA), paving the way for a U.S. regulatory filing next year. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription